文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛

早期急性呼吸窘迫综合征中的高氧血症与过度氧疗:来自LUNG SAFE研究的启示

Hyperoxemia and excess oxygen use in early acute respiratory distress syndrome: insights from the LUNG SAFE study.
PubMed 文献 · Crit Care · 2020-03-31
一句话结论在早期ARDS中,高氧血症和过度氧疗常见但多不持续,多变量分析未发现其与不良结局独立相关。

该研究为LUNG SAFE研究的二次分析,纳入2005例符合早期ARDS标准的患者,按第1天高氧血症(PaO2>100 mmHg)、持续高氧血症或过度氧疗(高氧血症时FIO2≥0.60)分组。第1天高氧血症占30%,持续高氧血症占12%,高氧血症患者中过度氧疗占66%。多变量分析未发现第1天高氧血症、持续高氧血症或过度氧疗与不良临床结局独立相关;过度氧疗患者死亡率为42%,倾向性匹配的氧正常(PaO2 55-100 mmHg)患者为39%(P=0.47)。

要点

  • 早期ARDS第1天高氧血症(PaO2>100 mmHg)常见,占30%(607/2005),但持续至高氧血症仅占12%(250/2005)。
  • 高氧血症患者中过度氧疗(FIO2≥0.60)占66%(400/607),第2天多数高氧血症患者接受相对较低的FIO2。
  • 多变量分析未发现第1天高氧血症、持续高氧血症或过度FIO2使用与不良临床结局独立相关。
  • 过度氧疗患者死亡率为42%,倾向性匹配的氧正常(PaO2 55-100 mmHg)患者为39%,差异无统计学意义(P=0.47)。

适用人群与场景

  • LUNG SAFE研究中第1天和第2天符合急性低氧性呼吸衰竭ARDS标准的患者,共2005例纳入分析。

诊断标准与关键阈值

  • 高氧血症定义为第1天PaO2>100 mmHg。
  • 持续高氧血症定义为第1天和第2天均存在高氧血症。
  • 过度氧疗定义为高氧血症期间FIO2≥0.60。
  • 氧正常定义为PaO2 55-100 mmHg。
  • 低氧血症定义为PaO2<55 mmHg。

研究设计与关键结果

  • 研究类型为LUNG SAFE研究的二次分析,纳入2005例早期ARDS患者。
  • 第1天高氧血症占30%(607/2005),持续高氧血症占12%(250/2005),低氧血症(PaO2<55 mmHg)占6.5%(131/2005)。
  • 高氧血症患者中过度FIO2使用占66%(400/607),过度FIO2使用从第1天到第2天减少,第2天多数高氧血症患者接受相对较低的FIO2。
  • 多变量分析未发现第1天高氧血症、持续高氧血症或过度FIO2使用与不良临床结局独立相关。
  • 过度氧疗患者死亡率为42%,倾向性匹配的氧正常(PaO2 55-100 mmHg)患者死亡率为39%,P=0.47。

证据类型、等级与局限

  • 证据类型:LUNG SAFE研究的二次分析(观察性队列研究)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者指出,高氧血症和过度氧疗在早期ARDS中常见但多不持续,本队列中未发现其与患者结局相关。

指南或共识出处

  • LUNG SAFE研究(Large observational study to UNderstand the Global impact of Severe Acute respiratory FailurE),注册号NCT02010073。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Concerns exist regarding the prevalence and impact of unnecessary oxygen use in patients with acute respiratory distress syndrome (ARDS). We examined this issue in patients with ARDS enrolled in the Large observational study to UNderstand the Global impact of Severe Acute respiratory FailurE (LUNG SAFE) study.

METHODS: In this secondary analysis of the LUNG SAFE study, we wished to determine the prevalence and the outcomes associated with hyperoxemia on day 1, sustained hyperoxemia, and excessive oxygen use in patients with early ARDS. Patients who fulfilled criteria of ARDS on day 1 and day 2 of acute hypoxemic respiratory failure were categorized based on the presence of hyperoxemia (PaO2 > 100 mmHg) on day 1, sustained (i.e., present on day 1 and day 2) hyperoxemia, or excessive oxygen use (FIO2 ≥ 0.60 during hyperoxemia).

RESULTS: Of 2005 patients that met the inclusion criteria, 131 (6.5%) were hypoxemic (PaO2 < 55 mmHg), 607 (30%) had hyperoxemia on day 1, and 250 (12%) had sustained hyperoxemia. Excess FIO2 use occurred in 400 (66%) out of 607 patients with hyperoxemia. Excess FIO2 use decreased from day 1 to day 2 of ARDS, with most hyperoxemic patients on day 2 receiving relatively low FIO2. Multivariate analyses found no independent relationship between day 1 hyperoxemia, sustained hyperoxemia, or excess FIO2 use and adverse clinical outcomes. Mortality was 42% in patients with excess FIO2 use, compared to 39% in a propensity-matched sample of normoxemic (PaO2 55-100 mmHg) patients (P = 0.47).

CONCLUSIONS: Hyperoxemia and excess oxygen use are both prevalent in early ARDS but are most often non-sustained. No relationship was found between hyperoxemia or excessive oxygen use and patient outcome in this cohort.

TRIAL REGISTRATION: LUNG-SAFE is registered with ClinicalTrials.gov, NCT02010073.

来源:Crit Care,查看原文。版权归原作者所有。

参考来源

  1. Madotto F, Rezoagli E, Pham T, et al. Hyperoxemia and excess oxygen use in early acute respiratory distress syndrome: insights from the LUNG SAFE study. Crit Care. 2020. PMID: 32234077. doi:10.1186/s13054-020-2826-6

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。